Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid in major non-cardiac surgery
NCT04803747Phase 4Completed
- Sponsor
- University of Manitoba
- Start
- Feb 2022
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tranexamic acid in hemorrhage, sponsored by University of Manitoba. Primary endpoints: Proportion of patients transfused RBCs at 90 days and Incidence of venous thromboembolism at 90 days. Started Feb 2022; status: completed.
02
Drugs
tranexamic acid
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT04803747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04803747.